China STEMI-PCI Program

This study is currently recruiting participants.
Verified October 2012 by Peking University First Hospital
Sponsor:
Collaborators:
Abbott Vascular
Sanofi
Information provided by (Responsible Party):
Yong Huo, Peking University First Hospital
ClinicalTrials.gov Identifier:
NCT01716884
First received: October 26, 2012
Last updated: NA
Last verified: October 2012
History: No changes posted
  Purpose
  1. Registration
  2. Performing in three stages
  3. Major aim: Much more and standard reperfusion therapy in STEMI patients

Condition
ST Segment Elevation Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: China STEMI-PCI Program

Resource links provided by NLM:


Further study details as provided by Peking University First Hospital:

Primary Outcome Measures:
  • The reperfusion ratio [ Time Frame: up to 1 day ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Door to Balloon time [ Time Frame: up to 1 day ] [ Designated as safety issue: No ]
  • BMS ratio [ Time Frame: up to 1 day ] [ Designated as safety issue: No ]
  • health economic evaluation [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 4000
Study Start Date: December 2011
Estimated Study Completion Date: June 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

STEMI Patients enrolled and followed up 1 year

Criteria

Inclusion Criteria:

  • Onset of STEMI within 12h
  • Onset of STEMI within 12-36h needing primary PCI

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01716884

Contacts
Contact: Yan Zhang, MD 8610-83575180 drzhy1108@163.com

Locations
China
Division of Cardiology, Peking University First Hospital Recruiting
Beijing, China, 100034
Principal Investigator: Yong Huo, MD         
Sponsors and Collaborators
Peking University First Hospital
Abbott Vascular
Sanofi
  More Information

No publications provided

Responsible Party: Yong Huo, Director of cardiovascular department, Peking University First Hospital
ClinicalTrials.gov Identifier: NCT01716884     History of Changes
Other Study ID Numbers: 2011[436]
Study First Received: October 26, 2012
Last Updated: October 26, 2012
Health Authority: China: Ministry of Health

Keywords provided by Peking University First Hospital:
STEMI
reperfution
primary PCI

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on April 16, 2014